Clinical Trials Browser

Waldenstrom Macroglobulinemia × acalabrutinib × Clear all

Waldenstrom Macroglobulinemia

NCT04624906 2026-02-04

BRAWM

Phase 2 Active not recruiting

63 enrolled

Lymphoid

Waldenstrom Macroglobulinemia

NCT02362035 2025-12-11

KEYNOTE145

Phase 1/2 Completed

161 enrolled 29 charts

LymphoidOther hematologic neoplasmPlasma cell

Burkitt Lymphoma, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT05065554 2025-12-05

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy

Phase 2 Active not recruiting

12 enrolled

Lymphoid

Waldenstrom Macroglobulinemia, Neuritis

Clinical Trials

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

BRAWM

KEYNOTE145

ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy